Author: admin
This week’s headlines included coverage of Xymogen Athletix brand positioned for athletes, EFSA approval of a rapeseed (canola) protein-fiber concentrate, and a new functional drink start-up aiming to tackle decision fatigue.Family-owned supplement company Xymogen has launched its first brand geared toward athletes.Xymogen Athletix is designed for both competitive and recreational athletes, building on a 20-year legacy of trust, research and innovation and created with evidence-based ingredients, according to the company.“Athletix was born from our family’s passion for performance and our responsibility to bring trusted, safe and science-backed nutrition to athletes everywhere,” said Brian Blackburn, Jr., chief science officer at Xymogen.…
Nature’s 2025 PhD surveyThis article is the first in a series discussing the results of Nature’s 2025 PhD survey. The next will look at what doctoral candidates wish they’d known when they set out on their degrees. The survey, created in partnership with Thinks Insight & Strategy, a research consultancy based in London, launched in May and was advertised on nature.com, in Springer Nature digital products and through e-mail campaigns. It had 3,785 self-selecting respondents across 107 countries, with 44% describing themselves as female, 25% as belonging to an ethnic minority in their country of study and 33% as studying…
Credit: selvanegra/GettyImages A new study led by researchers at the Icahn School of Medicine at Mount Sinai offers what they describe as one of the most detailed molecular maps to date of how brain cells fail to communicate in Alzheimer’s disease (AD), identifying a protein network that provides an important new target for future treatments. The research, published in Cell, found that in AD glial cells become overactive and neurons exhibit decreased functionality leading to increased inflammation and the accumulation of toxic proteins in the brain. “Alzheimer’s is not just about plaque buildup or dying neurons; it’s about how the…
US-based Stratum Nutrition has expanded into the Netherlands with a new office to boost its European presence. With its clinically validated nutraceuticals, the move seeks to bring local support and innovation, focused on joint health, cognitive support, beauty-from-within, and overall health. The company’s key products include NEM eggshell membrane for joint health, recognized for effectiveness and safety, and inner beauty solution Ovolux. These multicollagen products include types I, V, and X to support joints, hair, skin, and nails.“Expanding into Europe marks an important milestone in Stratum Nutrition’s growth journey,” says Arun Nair, Stratum Nutrition’s chief commercial officer. “Our goal has…
Whether you’re looking for dinner ideas to help you lose weight or options that are simply delicious, these low-calorie choices are packed with 6 grams of fiber and/or 15 grams of protein per serving to help you meet your goals. With balanced ingredients like whole grains, legumes, lean protein and a variety of veggies, these dinners like our High-Fiber Butternut Squash & Black Bean Enchilada Skillet or our Spanakopita-Inspired Skillet Beans fit well into the Mediterranean diet, which consistently ranks as one of the best healthy eating patterns you can follow. Love any of these recipes? Join MyRecipes to save,…
Walmart and Trader Joe’s pasta meals flagged for possible Listeria contamination.CDC has linked 20 illnesses, 19 hospitalizations and 4 deaths to the broader outbreak.Shoppers should check fridges and freezers for affected meals and dispose safely. There’s an active public health alert on two types of ready-to-eat meals sold at Walmart and Trader Joe’s nationwide, according to the Department of Agriculture’s Food Safety and Inspection Service. This is due to a Listeria monocytogenes contamination. The following meals are part of the public health alert: Marketside Linguine with Beef Meatballs & Marinara Sauce: sold at Walmart in 12-ounce plastic trays with best-by…
Researchers at Queen Mary University of London’s School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that a new target of rapamycin (TOR) inhibitor, rapalink-1, which is in development against cancer, prolongs chronological lifespan. The study, headed by Charalampos Rallis, PhD, revealed TOR-regulated genes with unknown roles in aging, and could shed new light on how drugs and natural metabolites can influence lifespan through the TOR pathway. Senior and corresponding author Rallis, together with first author Juhi Kumar, PhD, and Kristal Ng, PhD, reported on their findings in Communications Biology, in a paper…
Donald Trump’s America First Global Health Strategy has been largely welcomed by global health experts, but some have raised concerns over the practicalities of its implementation and gaps in its policies.Released on 18 September,1 the strategy seeks to provide some clarity after months of uncertainty and cuts to health aid programmes to which the US has historically been an important donor. The 35 page document is based on “three pillars” with the stated aim to make the US safer, stronger, and more prosperous.First, it proposes to keep the US safer by monitoring and quickly containing infectious disease outbreaks “before they…
Company targets confirmatory trials of immunomodulator shown to slow cognitive decline when used as a control arm. Longevity biotech Advantage Therapeutics has secured a $2.5 million Phase II Small Business Innovation Research grant from the National Institute on Aging to advance its Alzheimer’s disease candidate AD04. The Miami-based biotech is preparing to launch confirmatory Phase 2b clinical trials in Europe to evaluate the therapy’s safety and efficacy in early-stage patients. With a long history of use as a vaccine adjuvant in both human and animal programs, Advantage is repurposing AD04 as a new class of Alzheimer’s therapy with potential both…
Credit: boonchai wedmakawand/Getty Images Researchers at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, and Yonsei University College of Medicine in Seoul, South Korea, have found that 99% of people who suffer a cardiac event already have at least one cardiovascular risk factor years before, refuting the common belief that heart disease often occurs without previous warning signs. In their study, published in The Journal of the American College of Cardiology and titled “Very High Prevalence of Nonoptimally Controlled Traditional Risk Factors at the Onset of Cardiovascular Disease,” the researchers took a closer look at how having at…